Advertise on podcast: KGI: Innovation in Applied Life Sciences & Healthcare

In this episode of the KGI podcast, Dr. Joel West, professor of innovation and entrepreneurship and program director for KGI's Master of Business and Science program, talks about his background, the MBS and CBM program, and the industry's future.

In this episode of the KGI podcast, Dr. Anna Hickerson, associate professor and program director for KGI's Master of Science in Medical Device Engineering program, talks about her background, the med device program, and the industry's future.

This is the fifth episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, Dr. Stephen Kingsmore discusses reviewing the first 10 years of genome-informed healthcare for children and predicting the next 10 years. This was recorded on January 19, 2023, in Claremont as part of KGI's Speaker Series.

In this episode of the KGI podcast, we sat down with Dr. Barbara Fortini, associate professor of genetics and the program director of the one-of-a-kind Master of Science in Human Genetics and Genomic Data Analytics (MSGDA) program, to discuss her background, history of the MSGDA program, and why it is important.

In this episode of the KGI podcast, one of KGI's founding faculty members, Dr. James Sterling, program director of the PhD in Applied Life Sciences program, discusses his various roles at KGI and talks about the PhD program and the future of a doctorate degree.

KGI welcomes Senior Director and Instructor of the Postbaccalaureate Programs Dr. Joon Kim to the podcast to discuss the Postbaccalaureate Premedical Certificate and Postbaccalaureate Pre-PA Certificate programs. 

KGI joins Dr. Cynthia Martinez, Dean of the School of Community Medicine, for a second podcast to discuss KGI's ground-breaking Master of Science in Community Medicine program.   The fully online, two-year program is revolutionizing how we educate future physicians, healthcare providers, and health professionals in the sciences and technologies that matter today—and are already changing how healthcare will be provided tomorrow.

This is the fourth episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we listen to KGI's Dr. Kiana Aran talk about her journey to freedom through science. Dr. Paul Grint moderates the talk. This was recorded on November 1, 2022, in San Diego as part of KGI's Speaker Series.

This is the third episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we share a delightful conversation between KGI President Sheldon Schuster as he talked with integral founding members of the institute: Bonnie Busenberg, Stephen McCormack, Bob Curry, and Greg Dewey. The group reminisced about the early days at KGI, recalled memories of the founding President, Hank Riggs, and talked about the struggles, victories, and, ultimately, KGI’s future.

In this episode of the KGI podcast, we feature KGI Board of Trustees member Dr. Carol Nacy, who gave an Industry Talk to the KGI community on October 13, 2022.  Nacy is a founder and the Chief Executive Officer of Sequella, Inc., a privately-held pharmaceutical company that discovers and develops treatments for life-threatening infectious diseases. Before Sequella, Nacy was EVP and Chief Scientific Officer at EntreMed, Inc. She left EntreMed to establish Sequella, Inc. and was part-time Chief Scientific Officer for Anergen, Inc., a California company focused on autoimmune diseases. There, she worked with the Management Team to position the company for acquisition by Corixa Corp. Before her business experience, Nacy was a career scientist and science manager for 17 years at Walter Reed Army Institute of Research. In 2002, Nacy was named a Top 50 Innovator in the U.S. by Inc. Magazine, Entrepreneur of the Year by Women in BIO in 2004, and the state of Maryland named her in its Top 100 Business Women in 2005.

This is the second episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we hear from former KGI School of Community Medicine Dean Dr. David Lawrence on the future of healthcare. The discussion was recorded on October 7, 2022, during KGI’s Founder’s Day celebration. KGI appointed former Kaiser CEO Dr. David M. Lawrence as Dean of the KGI School of Community Medicine on March 17, 2020. He stepped down from that role in March of 2022 after a successful two years that included launching the brand-new Master of Science in Community Medicine program. While serving as the CEO and Chairman of the Kaiser Foundation Health Plan and Hospitals from 1991 to 2002, Lawrence focused the nation’s attention on the issue of patient safety and the need for reform in healthcare delivery systems. Lawrence served on the KGI Board of Trustees in 2019. He retired from Kaiser Permanente in 2002 after his 10-year tenure as CEO and Chairman. Prior to joining Kaiser Permanente in 1981, Lawrence worked in Public Health and Human Services in Multnomah County, OR; on the faculty of the University of Washington School of Public Health and Community Medicine and the School of Medicine; as an advisor to the Ministry of Health of Chile; and as a Peace Corps Physician in the Dominican Republic and Washington, DC.

This episode kicks off a series of special podcasts for KGI's 25th anniversary. In this episode, we hear from KGI Board of Trustee members Dr. Ross Grossman, Teresia Bost, and Dr. Lydia Villa-Komaroff on the future of biotech and the life sciences. The discussion was recorded on October 7, 2022, during KGI's Founder's Day celebration. Grossman served as the Chief Human Resources Officer at Regeneron Pharmaceuticals from 2002 until his retirement in 2013, later returning to that role in April 2015 until his second retirement in May 2016. He previously held senior Human Resources roles at Novartis Pharmaceuticals, Prudential Financial, and UBS. Bost serves as General Counsel at health technology company 54gene, overseeing legal, compliance, and cybersecurity functions. 54gene advances the state of healthcare through large-scale discovery and translational research, advanced molecular diagnostics, and clinical programs for the benefit of Africans and the global population. Villa-Komaroff is a molecular biologist, an executive, and a diversity advocate, in addition to being founder and principal of Intersections SBD Consulting. She is also the Chair of the KGI School of Community Medicine Board of Governors. The three panelists are joined by moderator Bonnie Anderson, CoFounder and Executive Chair of Veracyte. Bonnie is also a KGI Trustee Emeritus and Most Influential Honoree.